{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:00:39Z","timestamp":1793509239406,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","award":["201920101001"],"award-info":[{"award-number":["201920101001"]}],"id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073711"],"award-info":[{"award-number":["82073711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114877","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T21:24:02Z","timestamp":1666819442000},"page":"114877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Synthesis and antineoplastic activity of ethylene glycol phenyl aminoethyl ether derivatives as FOXM1 inhibitors"],"prefix":"10.1016","volume":"244","author":[{"given":"Yan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuosong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Situ","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5748-7444","authenticated-orcid":false,"given":"Zhuorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114877_bib1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114877_bib2","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2022.114877_bib3","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1002\/cncr.32500","article-title":"Treatment of recurrent epithelial ovarian cancer","volume":"125","author":"Pignata","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejmech.2022.114877_bib4","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.18632\/oncotarget.2522","article-title":"miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma","volume":"5","author":"Dong","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2022.114877_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2022.114877_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat. Commun."},{"issue":"2016","key":"10.1016\/j.ejmech.2022.114877_bib7","first-page":"271","article-title":"Cancer treatment and survivorship statistics","volume":"66","author":"Miller","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2022.114877_bib8","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"ENGOT-OV16\/NOVA investigators, niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114877_bib9","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","article-title":"ARIEL3 investigators, Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Coleman","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114877_bib10","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/mc.23064","article-title":"Activation of Wnt signaling promotes olaparib resistant ovarian cancer","volume":"58","author":"Yamamoto","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejmech.2022.114877_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114877_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/1535-7163.MCT-12-0712","article-title":"FOX(M1) news\u2013it is cancer","volume":"12","author":"Halasi","year":"2013","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejmech.2022.114877_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/648137","article-title":"Analyzing association of the XRCC3 gene polymorphism with ovarian cancer risk","volume":"2014","author":"Yuan","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2022.114877_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.tig.2011.03.003","article-title":"Forkhead transcription factors: key players in health and disease","volume":"27","author":"Benayoun","year":"2011","journal-title":"Trends Genet."},{"key":"10.1016\/j.ejmech.2022.114877_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/carcin\/bgv018","article-title":"All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells","volume":"36","author":"Young","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejmech.2022.114877_bib16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1128\/MCB.01068-06","article-title":"Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes","volume":"27","author":"Tan","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2022.114877_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41392-020-00396-0","article-title":"Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2022.114877_bib18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/modpathol.2013.245","article-title":"Tubal origin of ovarian endometriosis","volume":"27","author":"Yuan","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejmech.2022.114877_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-017-0536-y","article-title":"FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients","volume":"36","author":"Tassi","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2022.114877_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2017.11.018","article-title":"The FOXO3-FOXM1 axis: a key cancer drug target and a modulator of cancer drug resistance","volume":"50","author":"Yao","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2022.114877_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005592","article-title":"Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells","volume":"4","author":"Bhat","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114877_bib22","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1038\/ncomms6165","article-title":"Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition","volume":"5","author":"Gormally","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2022.114877_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112902","article-title":"SP1-independent inhibition of FOXM1 by modified thiazolidinediones","volume":"209","author":"Tabatabaei Dakhili","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jmgm.2018.01.009","article-title":"Untying the knot of transcription factor druggability: molecular modeling study of FOXM1 inhibitors","volume":"80","author":"Tabatabaei-Dakhili","year":"2018","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2022.114877_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41420-022-01070-w","article-title":"Small molecule targeting FOXM1 DNA binding domain exhibits anti-tumor activity in ovarian cancer","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2022.114877_bib26","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1021\/jm010878g","article-title":"From hit to lead. Analyzing structure-profile relationships","volume":"44","author":"Poulain","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/jm034222u","article-title":"Scaffold hopping in de novo design. Ligand generation in the absence of receptor information","volume":"47","author":"Lloyd","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib28","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.bmc.2010.02.019","article-title":"Evaluation of retro-inverso modifications of HTLV-1 protease inhibitors containing a hydroxyethylamine isoster","volume":"18","author":"Tatsumi","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib29","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.1002\/anie.200902512","article-title":"Structural and functional evolution of a library of constitutional dynamic polymers driven by alkali metal ion recognition","volume":"48","author":"Fujii","year":"2009","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2022.114877_bib30","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1021\/acsomega.7b00701","article-title":"Efficient synthesis of amine-linked 2,4,6-trisubstituted pyrimidines as a new class of bacterial FtsZ inhibitors","volume":"2","author":"Chan","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2022.114877_bib31","first-page":"10647","article-title":"TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level","volume":"23","author":"Zhou","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2022.114877_bib32","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1080\/15384101.2020.1829824","article-title":"miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer","volume":"19","author":"Yang","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2022.114877_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejmech.2015.09.028","article-title":"Preliminary evaluation of \ufb02uoro-pegylated benzyloxybenzenes for quanti\ufb01cation of \u03b2-amyloid plaques by positron emission tomography","volume":"104","author":"Yang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10610278.2021.1895994","article-title":"Synthesis and kinetic resolution of directional isomers of [2]rotaxanes bearing a lariat crown ether wheel","volume":"33","author":"Makita","year":"2021","journal-title":"Supramol. Chem."},{"key":"10.1016\/j.ejmech.2022.114877_bib35","first-page":"1","article-title":"Synthesis and property of hydroquinone ether derivatives","volume":"11","author":"He","year":"1998","journal-title":"Shi You Hua Gong Gao Deng Xue Xiao Xue Bao"},{"key":"10.1016\/j.ejmech.2022.114877_bib36","series-title":"Process for Preparation of Mono-Aryl Diol under Catalysis of Light and Nickel","author":"Huang","year":"2018"},{"key":"10.1016\/j.ejmech.2022.114877_bib37","first-page":"772","article-title":"Plunger-scale molecular-level machines-supramolecular pseudorotaxanes controlled by acid-base interactions","volume":"70","author":"Xi","year":"2007","journal-title":"Huaxue Tongbao"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422007796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:56:59Z","timestamp":1759330619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422007796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":37,"alternative-id":["S0223523422007796"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114877","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and antineoplastic activity of ethylene glycol phenyl aminoethyl ether derivatives as FOXM1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114877"}}